Deschloroclotizolam or Clotizolam-2 is a new designer sedative drug thienotriazolodiazepine derivative. It has a similar structure to Fluclotizolam (synthesized in 1979 and not used in medicine and not participated in official sales).
Deschloroclotizolam has properties similar to benzodiazepine preparations (Brotizolam, Ciclotizolam, Deschloroetizolam, Etizolam, Fluclotizolam, Metizolam), as it interacts with the benzodiazepine site of the receptor. Toxicological and physiological properties of Deschloroclotizolam have not been studied. Deschloroclotizolam synthesized in the modern laboratory in compliance with all standards.
Deschloroclotizolam is a new designer drug designed for research and forensics.